Fiera Capital Corp Invests $3.15 Million in Docebo Inc. (NASDAQ:DCBO)

Fiera Capital Corp purchased a new stake in Docebo Inc. (NASDAQ:DCBO) during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 79,566 shares of the company’s stock, valued at approximately $3,154,000. Fiera Capital Corp owned about 0.24% of Docebo as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Bank of Montreal Can bought a new stake in shares of Docebo in the second quarter worth about $23,313,000. Acadian Asset Management LLC raised its holdings in Docebo by 100.3% during the 2nd quarter. Acadian Asset Management LLC now owns 249,477 shares of the company’s stock worth $9,863,000 after buying an additional 124,895 shares during the period. Bank of America Corp DE raised its holdings in Docebo by 45.3% during the 1st quarter. Bank of America Corp DE now owns 247,942 shares of the company’s stock worth $12,848,000 after buying an additional 77,318 shares during the period. CIBC Asset Management Inc lifted its stake in Docebo by 18.2% in the first quarter. CIBC Asset Management Inc now owns 244,163 shares of the company’s stock valued at $9,930,000 after buying an additional 37,619 shares in the last quarter. Finally, Baillie Gifford & Co. boosted its holdings in shares of Docebo by 17.4% in the second quarter. Baillie Gifford & Co. now owns 238,813 shares of the company’s stock valued at $9,464,000 after buying an additional 35,452 shares during the period. 45.96% of the stock is currently owned by institutional investors and hedge funds.

Docebo Trading Down 0.4 %

DCBO opened at $51.22 on Thursday. The company has a debt-to-equity ratio of 0.01, a current ratio of 2.03 and a quick ratio of 2.03. Docebo Inc. has a fifty-two week low of $29.40 and a fifty-two week high of $52.47. The company’s 50 day moving average price is $40.90 and its two-hundred day moving average price is $38.69. The firm has a market capitalization of $1.63 billion, a price-to-earnings ratio of 1,280.82 and a beta of 1.58.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on DCBO. Stifel Canada restated a “buy” rating on shares of Docebo in a report on Sunday, September 17th. Canaccord Genuity Group boosted their target price on Docebo from $45.00 to $50.00 and gave the company a “buy” rating in a research note on Friday, November 10th. TD Securities raised their price target on shares of Docebo from $54.00 to $55.00 and gave the stock a “buy” rating in a research note on Friday, November 10th. Needham & Company LLC assumed coverage on shares of Docebo in a report on Tuesday. They issued a “buy” rating and a $56.00 price objective on the stock. Finally, Morgan Stanley increased their target price on shares of Docebo from $49.00 to $53.00 and gave the stock an “overweight” rating in a report on Friday, November 10th. One research analyst has rated the stock with a hold rating and eight have given a buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $52.25.

About Docebo

Docebo Inc operates as a learning management software company that provides artificial intelligence (AI)-powered learning platform in North America, Europe, and the Asia-Pacific region. It offers Learning Management System (LMS) to train internal and external workforces, partners, and customers. The company's cloud platform consists of a learning suite, which includes Docebo Learn LMS, a cloud-based learning platform that allows learning administrators to deliver personalized learning; Docebo Shape, an AI-based learning content creation tool, which enables learning administrators to turn internal and external resources into engaging, multilingual, and microlearning content to share across the business; and Docebo Content that provides off-the-shelf learning content by partnering content specialist.